Evidence map›Paper›PMID 31363939›Full record

ArticleEJNMMI research2019

Sensitivity of

Matthijs C F Cysouw, Gerbrand M Kramer, Dennis Heijtel, Robert C Schuit, Michael J Morris, Alfons J M van den Eertwegh, Jens Voortman, Otto S Hoekstra, Daniela E Oprea-Lager, Ronald Boellaard

Abstract read
In one paragraph

Article in EJNMMI research, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed.

  1. Repeatability of QuantitativeJournal of nuclear medicine : official publication, Society of Nuclear Medicine · 2020
    Trial
  2. Article
  3. [Diagnostics (Basel, Switzerland) · 2023
    Review
  4. Review
  5. Article
  6. Article
  7. Article
  8. Review
  9. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Matthijs C F CysouwAmsterdam UMC, Vrije Universiteit Amsterdam, Department of Radiology and Nuclear Medicine, Cancer Center Amsterdam, De Boelelaan 1117, Amsterdam, The Netherlands. m.cysouw@vumc.nl.ORCID http://orcid.org/0000-0001-5946-0173
Gerbrand M KramerAmsterdam UMC, Vrije Universiteit Amsterdam, Department of Radiology and Nuclear Medicine, Cancer Center Amsterdam, De Boelelaan 1117, Amsterdam, The Netherlands.
Dennis HeijtelPhilips Healthcare, Best, The Netherlands.
Robert C SchuitAmsterdam UMC, Vrije Universiteit Amsterdam, Department of Radiology and Nuclear Medicine, Cancer Center Amsterdam, De Boelelaan 1117, Amsterdam, The Netherlands.
Michael J MorrisDepartment of Medicine, Genitourinary Oncology Service, Memorial Sloan Kettering Cancer Center, 353 E 68th St, New York, NY, 10065, USA.
Alfons J M van den EertweghAmsterdam UMC, Vrije Universiteit Amsterdam, Department of Medical Oncology, Cancer Center Amsterdam, De Boelelaan 1117, Amsterdam, The Netherlands.
Jens VoortmanAmsterdam UMC, Vrije Universiteit Amsterdam, Department of Medical Oncology, Cancer Center Amsterdam, De Boelelaan 1117, Amsterdam, The Netherlands.
Otto S HoekstraAmsterdam UMC, Vrije Universiteit Amsterdam, Department of Radiology and Nuclear Medicine, Cancer Center Amsterdam, De Boelelaan 1117, Amsterdam, The Netherlands.
Daniela E Oprea-LagerAmsterdam UMC, Vrije Universiteit Amsterdam, Department of Radiology and Nuclear Medicine, Cancer Center Amsterdam, De Boelelaan 1117, Amsterdam, The Netherlands.
Ronald BoellaardAmsterdam UMC, Vrije Universiteit Amsterdam, Department of Radiology and Nuclear Medicine, Cancer Center Amsterdam, De Boelelaan 1117, Amsterdam, The Netherlands.

Funding

X-RAY CRYSTALLOGRAPHYP30CA008748 · NCI · SLOAN-KETTERING INSTITUTE FOR CANCER RES · PI Hongbiao Carl Lekaye · 1985 to 2026
$347.4M
Movember Foundation GAP2NCI NIH HHS P30 CA008748
6 · The paper itself

Abstract

objectivesWhole body [

methodsWhole body [

resultsCount reduction increased liver coefficient of variation from 9.0 to 12.5% and from 10.8 to 13.2% for EARL1 and EARL2, respectively. SUVs of EARL2 images were 12.0-21.7% higher than EARL1. SUVs of 100% and 50% count data were highly correlated (R

conclusionsReducing [

Indexed as

[18F]-fluordihydrotestosteroneCount statisticsmCRPCPET-CTReconstruction

Identifiers

PMID31363939
PMCPMC6667590

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.